$3.95
+0.15 (+3.95%)
Open$3.66
Previous Close$3.80
Day High$3.98
Day Low$3.66
52W High$10.48
52W Low$3.80
Volume—
Avg Volume77.7K
Market Cap40.22M
P/E Ratio—
EPS$-2.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+105.6% upside
Current
$3.95
$3.95
Target
$8.12
$8.12
$6.66
$8.12 avg
$12.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 32.78M | 20.57M | 9.68M |
| Net Income | -13,696,903 | -7,735,449 | 2.71M |
| Profit Margin | -41.8% | -39.7% | 28.0% |
| EBITDA | -25,573,577 | -15,245,292 | 3.39M |
| Free Cash Flow | — | — | 1.90M |
| Rev Growth | +59.4% | +59.4% | +15.5% |
| Debt/Equity | — | — | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |